OPKO Health’s GeneDx business Presenting at National Society of Genetic Counselors Annual Meeting

OPKO Health (Ireland)

About the role

October 21, 2015 11:30pm EDT

Download as PDF

Focus is on Genetic Diagnosis of Rare Disease

PITTSBURGH--(BUSINESS WIRE)--

OPKO Health, Inc. (NYSE:OPK) announced today that GeneDx, a business

unit of OPKO will be presenting at the National Society of Genetic

Counselors (NSGC) 34 th Annual Education Conference in

Pittsburgh, PA. GeneDx staff and genetic counselors will participate at

the conference as individual speakers, poster presenters and exhibitors.

GeneDx is also sponsoring a networking reception with partners and

colleagues. Details are below

GeneDx BOOTH: #115

RSVP

here for the Annual GeneDx Happy Hour

When: Thursday, October

22, at 8:00pm

Where: Il Tetto Rooftop Bar at Sienna Mercato

GeneDx Lunch Session and Presentation

Diagnostic

Testing, Evolving Phenotypes, and Impact on Patient Care: A

GeneDx Update on XomeDxXpress and Inherited Cancer Testing

When: Friday, October 23 at 11:45 pm

Where: Allegheny Grand

Ballroom, Westin Hotel

Who: Sara Knapke, MS, CGC; Audra Bettinelli,

MS, CGC; Stephanie DeWard, MS, CGC

GeneDx Individual Speaker Presentations

Pre‐Conference

Symposium ‐ Diagnostic Exome Sequencing as the Standard of Care

When

Wednesday, October 21 at 9:00 am

Where: Room 315/316

Who: Jane

Juusola, PhD, FACMG

Concurrent Paper Session (Clinical Care: Pediatrics & Adult Track) ‐ The

Clinical Utility of a Multi‐Gene Panel for Neuromuscular Disorders

(#1311)

When: Saturday, October 24 at 3:15 pm

Where: Room

315/316

Who: Meg Bradbury, MS, CGC, MSHS

GeneDx Poster Presentations

NOTE: Odd

Numbered Posters: Thursday, October 22, 2015 2:00 pm – 3:00 pm

Even

Numbered Posters: Friday, October 23, 2015 1:15 pm – 2:15 pm

Poster# 64

Comparing Yields and Referral Criteria for the

Lynch/Colorectal High Risk Panel and the Colorectal Cancer Panel

Anna

McGill, MS, LCGC

Poster# 78

Yield of Genetic Testing for Hereditary Cancer

Among Male Patients

Kristin Theobald, MS, LCGC

Poster# 153

Genetic Testing Strategies for Patients With

Epilepsy and Neurodevelopmental Disorders

Amy Decker, MS, CGC

Poster# 154

Mutations in SPATA5 Are Associated With a

Novel Autosomal Recessive Disorder of Microcephaly, Intellectual

Disability, Seizures and Hearing Loss

Stephanie DeWard, MS, CGC

Poster# 169

Whole Exome Sequencing Identifies the First

PANX1 Germline Mutation in an Individual with Intellectual Disability,

Hearing Loss, Endocrine Dysfunction and Skeletal Abnormalities

Kara

Levine, MS, CGC

Poster# 192

De Novo Pathogenic Variants in DDX3X Are a

Novel Cause of Intellectual Disability in Females

Leah

Williams, MS, CGC

Poster# 194

Whole Exome Sequencing Identifies POGZ

Mutations as a Cause of Neurodevelopmental Disorders and Microcephaly

Nora

Alexander, MS, CGC

Poster# 218

Mutations in ARID2 Are Associated with

Syndromic Intellectual Disabilities

Rebecca Willaert, MS, CGC

Poster# 268

Compound Heterozygosity of Two MECP2

Deletions with Paternal Inheritance of a Late-Truncating Mutation in a

Female With Atypical Rett Syndrome

Dana Stolar, MS, CGC

View source version on businesswire.com: http://www.businesswire.com/news/home/20151021006852/en/

Sheeran Communication

Lisa Sheeran, +1-510-710-1004

Source: OPKO Health, Inc.

Released October 21, 2015

email Email Alerts

location_city Company Profile

contact_page Contacts

rss_feed RSS News Feed

account_tree Sitemap

Apply on OPKO Health (Ireland)’s careers page

More jobs at OPKO Health (Ireland)